Novartis AG (NVS)
102.86
+0.29
(+0.28%)
USD |
NYSE |
May 20, 16:00
102.86
0.00 (0.00%)
After-Hours: 16:31
Novartis Long Term Notes Receivable (Quarterly)
Long Term Notes Receivable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Long Term Notes Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -- |
September 30, 2023 | -- |
June 30, 2023 | -- |
March 31, 2023 | -- |
December 31, 2022 | -- |
September 30, 2022 | -- |
June 30, 2022 | -- |
March 31, 2022 | -- |
December 31, 2021 | -- |
September 30, 2021 | -- |
June 30, 2021 | -- |
March 31, 2021 | -- |
December 31, 2020 | -- |
September 30, 2020 | -- |
June 30, 2020 | -- |
March 31, 2020 | -- |
December 31, 2019 | -- |
September 30, 2019 | -- |
June 30, 2019 | -- |
March 31, 2019 | -- |
December 31, 2018 | -- |
September 30, 2018 | -- |
June 30, 2018 | -- |
March 31, 2018 | -- |
December 31, 2017 | -- |
Date | Value |
---|---|
September 30, 2017 | -- |
June 30, 2017 | -- |
March 31, 2017 | -- |
December 31, 2016 | -- |
September 30, 2016 | -- |
June 30, 2016 | -- |
March 31, 2016 | -- |
December 31, 2015 | -- |
September 30, 2015 | -- |
June 30, 2015 | -- |
March 31, 2015 | -- |
December 31, 2014 | -- |
September 30, 2014 | -- |
June 30, 2014 | -- |
March 31, 2014 | -- |
December 31, 2013 | -- |
September 30, 2013 | -- |
June 30, 2013 | -- |
March 31, 2013 | -- |
December 31, 2012 | -- |
September 30, 2012 | -- |
June 30, 2012 | -- |
March 31, 2012 | -- |
December 31, 2011 | -- |
September 30, 2011 | -- |
Non-current Note Receivables Definition
Non-current Note Receivables are the written obligations the creditors receive from the debtors in exchange for funds that are not due within the next twelve months. It is part of a company’s long term assets.
Long Term Notes Receivable (Quarterly) Range, Past 5 Years
Long Term Notes Receivable (Quarterly) Benchmarks
Sandoz Group AG | -- |
Amgen Inc | -- |
AstraZeneca PLC | -- |
Novo Nordisk A/S | -- |
MorphoSys AG | -- |